David Isenberg
Member of Clinical Advisory Board
Pharmaceutical
XTL Biopharmaceuticals
India
Biography
Prof. David Isenbergm MD serves as an Academic Director of Rheumatology at University College London. Prof. Isenberg has been associated with the SLE cohort at University College Hospital, London (650 patients) since 1979. He serves as the Chairman the BILAG Group, responsible for developing the BILAG index. He served as the Chairman of SLICC and Ex-President of the British Society for Rheumatology from 2004 to 2006 and Ex-Chairman of the BSR's Biologics Register Committee from 2006 to 2011. He has been a Member of Clinical Advisory Board at XTL Biopharmaceuticals Ltd. since September 3, 2015. He serves as the Chairman of Lupus UK's Research Committee and a Local Clinical Trials Network Enabling Group in North London. Prof. Isenberg won the Hess prize (2010) awarded by the Lupus Foundation of America for outstanding contribution to SLE Research “ the first non-North American to win it. Prof. Isenberg was trained at St Bartholomew's Hospital in London and did his clinical training in North London hospitals and his basic research training in laboratories directed by Ivan Roitt (The Middlesex Hospital London) and Robert Schwartz (New England Medical Centre in Boston).
Research Interest
Biotechnology , Pharmaceutical Sciences